אסטוניה -
אסטונית -
Ravimiamet
braunol nahalahus
b. braun melsungen ag - joodpovidoon - nahalahus - 75mg 1g 100ml 1tk; 75mg 1g 1000ml 1tk
אסטוניה -
אסטונית -
Ravimiamet
braunovidon salv
b. braun melsungen ag - joodpovidoon - salv - 100mg 1g 20g 1tk; 100mg 1g 100g 1tk
אסטוניה -
אסטונית -
Ravimiamet
solutio iodi spirituosa nahalahus
riga pharmaceutical plant - jood - nahalahus - 5% 20ml 1tk
אסטוניה -
אסטונית -
Ravimiamet
kenostart spray and dip nisakastutus-/nisasprei lahus
cid lines - jood - nisakastutus-/nisasprei lahus - 3mg 1g 25000ml 1tk; 3mg 1g 20000ml 1tk; 3mg 1g 60000ml 1tk; 3mg 1g 200000ml 1tk; 3mg 1g 1000ml 1tk; 3mg 1g 10000ml 1tk
אסטוניה -
אסטונית -
Ravimiamet
kenostart nisakastutuslahus
cid lines - jood - nisakastutuslahus - 3mg 1g 20000ml 1tk; 3mg 1g 5000ml 1tk; 3mg 1g 10000ml 1tk; 3mg 1g 60000ml 1tk
אסטוניה -
אסטונית -
Ravimiamet
iodine valentis nahalahus
valentis uab - jood - nahalahus - 50mg 1ml 10ml 1tk
אסטוניה -
אסטונית -
Ravimiamet
iodovet spray 2,5% nahasprei, lahus
cp-pharma handelsgesellschaft mbh - joodpovidoon - nahasprei, lahus - 2,5% 250ml 1tk
האיחוד האירופי -
אסטונית -
EMA (European Medicines Agency)
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).
האיחוד האירופי -
אסטונית -
EMA (European Medicines Agency)
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).